Le Lézard
Classified in: Health, Sports and recreation
Subject: PER

Renowned International Sports & Entertainment Industry Executive, Tom Wright, Joins Ortho RTi Board of Directors

KIRKLAND, QC, Oct. 3, 2017 /CNW Telbec/ - Ortho Regenerative Technologies Inc. ("Ortho RTi" or the "Corporation"), an emerging Orthopaedic and Sports Medicine Technology company, today announced that Tom Wright has been appointed to its Board of Directors. 

Mr. Wright has an accomplished history of success in the North American, Australian and New Zealand sports and entertainment industry. In a career spanning more than 35 years, he has led organizations and inspired teams representing world-class brands, including Ultimate Fighting Championship, Canadian Football League, adidas, Salomon, Taylor Made and Spalding.  His expertise includes business strategy development and implementation, general management, sales and marketing, corporate and product branding, operations and governance. Mr. Wright has also been significantly involved with the community, serving as a volunteer with Special Olympics Canada for more than 30 years, including as the organization's National Board Chairman from 2004 to 2007.

Mr. Wright is a graduate of the University of Toronto with a Bachelor of Physical and Health Education, and holds a Masters of Business Administration from the Schulich School of Business, York University. Mr. Wright is also a graduate of the Institute of Corporate Directors, Directors Education Program at the Rotman School of Management obtaining his ICD.D in 2017.

"I am excited to join the Ortho RTi board at this important stage in its corporate development," commented Mr. Wright. "Having worked with and around athletes for most of my career, I know all too well how devastating a soft tissue sports injury can be if not treated successfully.  Ortho RTi's product promise is highly attractive and I believe that I can help build awareness, acceptance and adoption as we move forward."

"On behalf of everyone at Ortho RTi, I would like to welcome Tom to our team," said the Corporation's Executive Chairman and CEO, Dr. Brent Norton. "Tom has extensive experience advising companies and a successful record in managing the transformation of high growth, complex organizations. That, combined with his well-earned reputation for creativity, drive and integrity, and his strong network of contacts in both amateur and professional sports, should prove to be a tremendous asset to our Board and to our shareholders."   

About Ortho Regenerative Technologies Inc.

Ortho RTi is an emerging Orthopaedic and Sports Medicine technology company dedicated to the development of novel therapeutic tissue repair devices to dramatically improve the success rate of sports medicine surgeries. We are committed to improving patients' lives through increasing the success rates of surgeries for soft tissue injuries. Our proprietary biopolymer has been specifically designed to increase the healing rates of sports related injuries to ligaments, tendons and cartilage. The polymer can be directly placed into the site of injury by a surgeon during a routine operative procedure without significantly extending the time of the surgery and without further intervention. Visit us on the internet at www.orthorti.com.

Forward-Looking Statements

This news release may contain certain forward-looking statements regarding the Corporation's expectations for future events. Such expectations are based on certain assumptions that are founded on currently available information. If these assumptions prove incorrect, actual results may differ materially from those contemplated by the forward-looking statements contained in this press release. Factors that could cause actual results to differ include, amongst others, uncertainty as to the final result and other risks. The Corporation disclaims any intention or obligation to publicly update or revise any forward- looking statements, whether as a result of new information, future events or otherwise, other than as required by security laws.


SOURCE Ortho Regenerative Technologies Inc.

These press releases may also interest you

at 04:00
LAKEWOOD, Colo., July 19, 2018 /PRNewswire-PRWeb/ -- Trumpet Behavioral Health ("Trumpet") is pleased to announce the appointment of Linda LeBlanc, Ph.D., BCBA-D®, to editor in chief of the Journal of Applied Behavior Analysis (JABA). Dr. LeBlanc was...

at 04:00
IBM today announced that several new European clients have selected IBM Watson Internet of Things (IoT) technologies. New contracts signed with Spanish electricity grid operator Red Eléctrica de España, Italian elderly care provider Cooperativa...

at 02:33
Shanghai Green Valley Pharmaceutical Co., Ltd. (Green Valley) today announced that its Phase 3 Study of Sodium Oligomannurarate (GV-971) Capsules on mild-to-moderate Alzheimer's disease met its primary endpoint. This randomized, double-blinded and...

at 02:21
INTERIM REPORT JANUARY ? JUNE 2018 THE PERIOD AND THE SECOND QUARTER Net sales amounted to MSEK 756.5 (281.8), of which the second quarterly MSEK 489.4 (142.5). This corresponds to an increase of 168.5%, and for the second quarter of 243.5%....

at 02:00
STRICTLY FOR EUROPEAN BUSINESS AND MEDICAL TRADE MEDIA ONLY Intrarosa® is an innovative treatment for vulvovaginal atrophy in post-menopausal women  Strengthens Theramex's position as a leader in Women's Health  Today, Theramex and...

at 02:00
Beckman Coulter announced today the European launch of DxONE PROService, a custom remote-service application that enables laboratories to help ensure fast turnaround times for important patient test results through continuous instrument monitoring....

News published on 3 october 2017 at 07:00 and distributed by: